Search results

Martin L. Olsson, professor of Transfusion Medicine at Lund University, has received the 2025 President’s Award from the Association for the Advancement of Blood and Biotherapies (AABB). The citation reads: “For important, pioneering research and leadership that has advanced the field of transfusion medicine, transplantation and biotherapies, and has improved donor and patient safety.”“The award h

https://www.medicine.lu.se/article/martin-l-olsson-receives-presidents-award - 2025-12-11

During two well-attended days, researchers, healthcare professionals and interested members of the public gathered in Malmö and Lund to take part in the latest research in the field. Research Day 2025 with the theme "Children's minds taken seriously – About Children's and Young People's Mental Health", offered a wide-ranging program of lectures, discussions and films. Moderator Lisa Kirsebom led t

https://www.medicine.lu.se/article/young-peoples-mental-health-focus-research-day - 2025-12-11

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.medicine.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2025-12-11

How can a tiny genetic change alter the body´s sugar balance? At Lund University, researchers have used stem cells to create two versions of the same cell – one carrying the genetic variant and one without – to see how melatonin affects insulin-producing cells and contributes to development of type 2 diabetes. Study summarySkin cells from a person carrying a risk gene for type 2 diabetes were “rep

https://www.medicine.lu.se/article/stem-cell-technology-reveals-new-insights-melatonin-and-diabetes - 2025-12-11

Jonna Bornemark, professor of philosophy at Södertörn University, Sara Heyman, foreign correspondent at Radio Sweden/Ekot, and Roger Barker, professor of clinical neuroscience at the University of Cambridge, have been appointed honorary doctors for 2026 at the Faculty of Medicine. A philosopher who deepens and renews the public conversation on ethics, judgement, and views of humanity within health

https://www.medicine.lu.se/article/philosopher-journalist-and-leading-neuroscientist-appointed-new-honorary-doctors - 2025-12-11

Diabetes researchers at Lund University have previously shown that people with diabetes can be stratified into five subgroups with differing disease progression. A new study by the same researchers provides increased evidence for the clinical relevance of the classification system. The researchers also present new findings of significant differences between subgroups in the development of complica

https://www.medicine.lu.se/article/new-research-classification-diabetes-identifies-high-risk-group - 2025-12-11

(DIABETES) After more than a decade of stagnation, there is a major surge in kidney research effort. New drugs and biomarkers make it possible to detect and slow the progression of the disease earlier – something that long seemed unattainable. This will impact people with diabetes, for whom kidney damage is a serious long-term complication. “We are entering a new era. What is happening now is simi

https://www.medicine.lu.se/article/hope-kidney-care - 2025-12-11

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.medicine.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2025-12-11

Lund University has climbed to first place in the world in the QS World University Rankings: Sustainability 2026. The ranking includes around 2,000 higher education institutions from about 100 countries and measures how universities contribute to a sustainable future – through research, education, and the way they operate as organisations. “Humble, proud, and inspired to continue moving forward –

https://www.medicine.lu.se/article/lund-university-ranked-best-world-sustainability - 2025-12-11

Christopher Douse, Associate Professor at Lund University’s Faculty of Medicine and group leader at the Lund Stem Cell Center, has been awarded a Consolidator Grant from the Swedish Society for Medical Research (SSMF). The five-year, SEK 11 million award will support his team’s research into how repetitive DNA sequences linked to neurological diseases are controlled in the development of the human

https://www.medicine.lu.se/article/decoding-repetitive-genome-christopher-douse-awarded-consolidator-grant-ssmf - 2025-12-11

Borders don’t just divide nations — they define our bodies too. At the skin and in the gut, our barrier organs form the frontline of defense against infection. Here, diverse communities of friendly microbes, the microbiota, help maintain health and keep these borders strong, backed up by an immune system ready to deploy antibodies against any intruder. Protecting these barrier organs is central to

https://www.medicine.lu.se/article/inta-gribonika-awarded-ssmf-starting-grant-research-skin-humoral-immunity - 2025-12-11

Eleven research centers across four thematic areas have been awarded funding in Forte's call for Research center grants 2025. Two of these centers will be led from Lund University, focusing on the themes of severe mental illness and women’s health and disease. The two new research centers at Lund University that have been granted long-term funding from Forte will be led by Ulrika Bejerholm in the

https://www.medicine.lu.se/article/forte-research-center-grants-2025 - 2025-12-11

Kompetensportalen, Lucat, Lupin, Lubas and LUCRIS. Those are the names of some of Lund University’s administrative systems. They are now also the names of five new bacteriophages that have recently been discovered in the ponds of Lund University’s Botanical Gardens. Bacteriophages – often abbreviated to phages – are viruses that attack bacteria. Phages are astonishingly effective assassins – these

https://www.medicine.lu.se/article/fishing-phages-lund-universitys-botanical-gardens - 2025-12-11

While researchers at Lund University have long contributed to understanding the heterogeneity of diabetes, a new report from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – co-chaired by Professor Paul W. Franks at Lund University – sets out an unprecedented global roadmap for the field. We spoke with Professor Paul W. Franks, who co-chaired the working group be

https://www.medicine.lu.se/article/global-call-rethink-diabetes - 2025-12-11

An increasing number of Swedes are getting tattoos and Sweden’s population is now one of the most tattooed in Europe. At the same time, the incidence of melanoma is increasing. A new epidemiological study from Lund University in Sweden suggests that tattoos could be a risk factor for melanoma. The state of research on tattoos and cancerIn view of the lack of knowledge concerning the long-term heal

https://www.medicine.lu.se/article/tattoos-could-be-risk-factor-melanoma - 2025-12-11

Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden shows a possible increased risk of basal cell carcinoma with certain blood pressure medications. The risk increase is relatively low—at most nine percent. “Blood pressure treatment should not be discontinued. But it’s good if doctors inform patients that extra sun protection ma

https://www.medicine.lu.se/article/important-use-sun-protection-during-blood-pressure-treatment - 2025-12-11

Electrotherapy using injectable nanoparticles delivered directly into the tumour could pave the way for new treatment options for glioblastoma, according to a new study from Lund University in Sweden. Glioblastoma is the most common and most aggressive form of brain tumour among adults. Even with intensive treatment, the average survival period is 15 months. The tumour has a high genetic variation

https://www.medicine.lu.se/article/electrotherapy-offers-hope-glioblastoma-treatment - 2025-12-11

The metal recycling industry is growing, not least due to the use of metals in green energy electronic components. Researchers at Lund University have examined the inhaled air of workers at 13 recycling companies in Sweden. Among the results, high levels of lead in air and elevated levels of multiple metals were detected in the blood of those who work in recycling. Different forms of metals are in

https://www.medicine.lu.se/article/harmful-exposure-metal-recycling - 2025-12-11

Researcher Paul Bourgine has been awarded the prestigious ERC Consolidator Grant to further study immunotherapies in cancer treatment. Can you describe your research?"ImmunhOss is built on the hypothesis that our bone marrow tightly regulates inflammation and immunosuppression. Now, what cells are involved, how they organise, and if they can have a dual role remains a mystery. Here we will develop

https://www.medicine.lu.se/article/paul-bourgine-awarded-erc-consolidator-grant - 2025-12-11

Lund University researcher Wenqian Xu will investigate the adoption of artificial intelligence (AI) in home care and the risks associated with its implementation, together with colleagues from Estonia, Finland, Norway, and Sweden. The project, called AMICA, has been granted SEK 14,9 million from NordForsk, along with an additional SEK 1.6 million from the Estonian Research Council. It is one of se

https://www.medicine.lu.se/article/ai-powered-care-home - 2025-12-11